PPH — VanEck Pharmaceutical ETF price, holdings and performance

VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF (NASDAQ: PPH) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
111.67
+1.17+1.06%
OverviewShort InterestFilings
PPHVanEck Pharmaceutical ETF·NASDAQ
111.67+1.06%
TA
Loading chart...
Screen all →
VXUS+1.28%$86.50VUG+1.57%$88.43VTV+0.52%$221.78VO+0.77%$80.15VB+0.67%$290.91VWO+1.23%$59.91VGT+2.15%$121.48VIG+0.59%$237.12
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y28.02%Total Holdings26Perf Week1.89%
SponsorVanEckETF TypeTagssectorReturn% 3Y13.02%AUM$995.86MPerf Month-1.35%
Fund FamilyBond TypeTags-Return% 5Y10.59%NAV/shPerf Quarter7.13%
Index-Average MaturityTags-Return% 10Y52W High117.99 -5.36%Perf Half Y9.27%
Index WeightingCommodity TypeTags-Return% SI52W Low85.91 29.98%Perf YTD8.24%
Active/PassiveQuant TypeTags-Flows% 1M0.00%Volatility1.04% 1.24%Perf Year26.29%
Dividend TTM2.17 (1.95%)ESG TypeTags-Flows% 3M48.11%ATR (14)1.82Perf 3Y36.10%
Dividend Ex-DateJul 01, 2026Dividend TypeSector/ThemeFlows% YTD51.98%RSI (14)48.50Perf 5Y49.55%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.44Perf 10Y88.47%
Expense0.36%Growth/ValueSMA20-1.44%Flows% 3YRel Volume0.28Prev Close110.50
Inverse/LeveragedMarket CapSMA500.01%Flows% 5YAvg Volume259.65KPrice111.67
IPO DateDec 20, 2011Option/ShortYes / YesSMA2004.94%52W Range %80%Volume72,053Change1.06%
Assets Under Management
00.30B0.60B0.90B1.20BFebMayJulSepNov'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Sep-15-26
Sep-15-2602:44PM
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?fool.com
Sep-11-26
Sep-11-2603:17AM
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.fool.com
Sep-07-26
Sep-07-2611:15AM
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFsYahoo
Sep-03-26
Sep-03-2608:05AM
The Market May Be Telling Us We're Entering A Capital Formation CycleSeekingAlpha
Sep-01-26
Sep-01-2607:31AM
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthroughzacks.com
Aug-27-26
Aug-27-2607:31AM
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Nowzacks.com
Aug-26-26
Aug-26-2604:57AM
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focusfool.com
Aug-24-26
Aug-24-2606:55AM
Where Is Growth?SeekingAlpha
Aug-19-26
Aug-19-2605:10PM
Healthy And Energized At New HighsSeekingAlpha
Aug-18-26
Aug-18-2609:42AM
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?fool.com
06:52AM
PPH vs. IYH: Which Healthcare Fund Is the Better Buy?fool.com
Aug-12-26
Aug-12-2608:48AM
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?fool.com
03:15AM
How Do You Invest In The AI Value Chain?SeekingAlpha
Aug-06-26
Aug-06-2609:20PM
Health Care Shakes Off A 5-Day SlideSeekingAlpha
Aug-05-26
Aug-05-2603:21AM
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?zacks.com
Fund

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR